Poly(dl:Lactic Acid-Castor Oil) 3:7-Bupivacaine Formulation: Reducing Burst Effect Prolongs Efficacy In Vivo
- 1 June 2010
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 99 (6) , 2732-2738
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Prolonged Local Anesthetic Action Through Slow Release from Poly(Lactic Acid Co Castor Oil)Pharmaceutical Research, 2008
- Stereoisomeric effect on in vitro drug release from injectable poly(lactic acid co castor oil) polyestersPolymers for Advanced Technologies, 2008
- Long acting local anesthetic–polymer formulation to prolong the effect of analgesiaJournal of Controlled Release, 2007
- Poly(sebacic acid‐co‐ricinoleic acid) biodegradable carrier for paclitaxel: In vitro release and in vivo toxicityJournal of Biomedical Materials Research Part A, 2004
- Physico-chemical characterization of a polymeric injectable implant delivery systemJournal of Controlled Release, 1995
- The influence of biodegradable microcapsule formulations on the controlled release of a proteinJournal of Controlled Release, 1994
- Improved clean-up procedure for the high-performance liquid chromatographic assay of bupivacaine enantiomers in human plasma and ultrafiltrate in the nanogram per milliliter rangeJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- Coated alginate microspheres: Factors influencing the controlled delivery of macromoleculesJournal of Applied Polymer Science, 1991
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPain, 1988
- Effect of non-uniform initial drug concentration distribution on the kinetics of drug release from glassy hydrogel matricesPolymer, 1984